West Pharmaceutical Services will hold its 2026 annual meeting on May 4, 2026 via webcast at www.virtualshareholdermeeting.com/WST2026. Shareholders will vote on the election of 11 director nominees to serve until the 2027 annual meeting. The agenda also includes an advisory vote on named executive officer compensation. Shareholders will also vote on ratifying the appointment of PricewaterhouseCoopers as independent registered public accounting firm for 2026 and a shareholder proposal on adopting an independent board chair policy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. West Pharmaceutical Services Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-026778), on March 12, 2026, and is solely responsible for the information contained therein.